PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors

BMC Biology

Volumn 2, Issue , 2004, Pages

  Schmidt, Enrico K ^a,b   Fichelson, Serge ^c   Feller, Stephan M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE; PROTEIN SHC; RAF PROTEIN; RAS PROTEIN; SOS PROTEIN; STEM CELL FACTOR; 1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CAFFEINE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MORPHOLINE DERIVATIVE; NITRILE;

ARTICLE; BIOCHEMISTRY; BLEEDING; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME STRUCTURE; ERYTHROID PRECURSOR CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPOXIA; MITOGENESIS; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; FETUS BLOOD; METABOLISM;

BUTADIENES; CAFFEINE; CELLS, CULTURED; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; ERYTHROID PRECURSOR CELLS; ERYTHROPOIETIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FETAL BLOOD; HUMANS; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MORPHOLINES; NITRILES; PHOSPHATIDYLINOSITOL 3-KINASES; RAS PROTEINS;

EID: 3242677738     PISSN: 17417007     EISSN: None     Source Type: Journal    
DOI: 10.1186/1741-7007-2-7     Document Type: Article

References (59)

1. Klingmuller U: The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells - signals emanating from the erythropoietin receptor. Eur J Biochem 1997, 249:637-647.
2. Constantinescu SN, Ghaffari S, Lodish HF: The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction. Trends Endocrinol Metab 1999, 10:18-23.
3. Wojchowski DM, Gregory RC, Miller CP, Pandit AK, Pircher TJ: Signal transduction in the erythropoietin receptor system. Exp Cell Res 1999, 253:143-156.
4. Lacombe C, Mayeux P: The molecular biology of erythropoietin. Nephrol Dial Transplant 1999, 14 Suppl 2:22-28.
5. Digicaylioglu M, Lipton SA: Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001, 412:641-647.
6. Brines M: What evidence supports use of erythropoietin as a novel neurotherapeutic? Oncology (Huntingt) 2002, 16:79-89.
7. Goldman SA, Nedergaard M: Erythropoietin strikes a new cord. Nat Med 2002, 8:785-787.
8. Koury MJ, Sawyer ST, Brandt SJ: New insights into erythropoiesis. Curr Opin Hematol 2002, 9:93-100.
9. Maxwell P, Ratcliffe P: Regulation of expression of the erythropoietin gene. Curr Opin Hematol 1998, 5:166-170.
10. Tamura K, Sudo T, Senftleben U, Dadak AM, Johnson R, Karin M: Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 2000, 102:221-231.
11. Harris AL: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002, 2:38-47.
12. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993, 74:227-236.
13. Klingmuller U, Wu H, Hsiao JG, Toker A, Duckworth BC, Cantley LC, Lodish HF: Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci U S A 1997, 94:3016-3021.
14. Constantinescu SN, Huang LJ, Nam H, Lodish HF: The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. Mol Cell 2001, 7:377-385.
15. Wu H, Liu X, Jaenisch R, Lodish HF: Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995, 83:59-67.
16. Lin CS, Lim SK, D'Agati V, Costantini F: Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev 1996, 10:154-164.
17. Qu CK, Shi ZQ, Shen R, Tsai FY, Orkin SH, Feng GS: A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development. Mol Cell Biol 1997, 17:5499-5507.
18. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF: Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 1999, 98:181-191.
19. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, Lodish HF: Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 2001, 98:3261-3273.
20. Liao HJ, Kume T, McKay C, Xu MJ, Ihle JN, Carpenter G: Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice. J Biol Chem 2002, 277:9335-9341.
21. Ohneda K, Yamamoto M: Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage. Acta Haematol 2002, 108:237-245.
22. Miller CP, Heilman DW, Wojchowski DM: Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms. Blood 2002, 99:898-904.
23. Pircher TJ, Geiger JN, Zhang D, Miller CP, Gaines P, Wojchowski DM: Integrative signaling by minimal erythropoietin receptor forms and c-Kit. J Biol Chem 2001, 276:8995-9002.
24. Zang H, Sato K, Nakajima H, McKay C, Ney PA, Ihle JN: The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis. Embo J 2001, 20:3156-3166.
25. Ketteler R, Heinrich AC, Offe JK, Becker V, Cohen J, Neumann D, Klingmuller U: A functional green fluorescent protein-erythropoietin receptor despite physical separation of JAK2 binding site and tyrosine residues. J Biol Chem 2002, 277:26547-26552.
26. Fichelson S, Chretien S, Rokicka-Piotrowicz M, Bouhanik S, Gisselbrecht S, Mayeux P, Lacombe C: Tyrosine residues of the erythropoietin receptor are dispensable for erythroid differentiation of human CD34+ progenitors. Biochem Biophys Res Commun 1999, 256:685-691.
27. Djordjevic S, Driscoll PC: Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases. Trends Biochem Sci 2002, 27:426-432.
28. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD: Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2001, 17:615-675.
29. Stein RC, Waterfield MD: PI3-kinase inhibition: a target for drug development? Mol Med Today 2000, 6:347-357.
30. Mayeux P, Dusanter-Fourt I, Muller O, Mauduit P, Sabbah M, Druker B, Vainchenker W, Fischer S, Lacombe C, Gisselbrecht S: Erythropoietin induces the association of phosphatidylinositol 3′-kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor. Eur J Biochem 1993, 216:821-828.
31. He TC, Zhuang H, Jiang N, Waterfield MD, Wojchowski DM: Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain. Blood 1993, 82:3530-3538.
32. Kubota Y, Tanaka T, Kitanaka A, Ohnishi H, Okutani Y, Waki M, Ishida T, Kamano H: Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase. Embo J 2001, 20:5666-5677.
33. Tang T, Prasad KS, Koury MJ, Brandt SJ: Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts. Biochem J 1999, 343 Pt 3:615-620.
34. Haseyama Y, Sawada K, Oda A, Koizumi K, Takano H, Tarumi T, Nishio M, Handa M, Ikeda Y, Koike T: Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Blood 1999, 94:1568-1577.
35. Cataldi A, Di Pietro R, Centurione L, Grilli A, Cutroneo G, Miscia S: Phosphatidylinositol-3-kinase activation and atypical protein kinase C zeta phosphorylation characterize the DMSO signalling in erythroleukemia cells. Cell Signal 2000, 12:667-672.
36. Myklebust JH, Blomhoff HK, Rusten LS, Stokke T, Smeland EB: Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells. Exp Hematol 2002, 30:990-1000.
37. Bouscary D, Pene F, Claessens YE, Muller O, Chretien S, Fontenay-Roupie M, Gisselbrecht S, Mayeux P, Lacombe C: Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood 2003, 101:3436-3443.
38. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, Williams RL: Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 2000, 6:909-919.
39. Sui X, Krantz SB, Zhao ZJ: Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways. Br J Haematol 2000, 110:63-70.
40. Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, Shepherd PR: Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. J Biol Chem 2002, 277:37124-37130.
41. Freyssinier JM, Lecoq-Lafon C, Amsellem S, Picard F, Ducrocq R, Mayeux P, Lacombe C, Fichelson S: Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol 1999, 106:912-922.
42. Berridge MJ, Lipp P, Bootman MD: The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000, 1:11-21.
43. Cullen PJ, Lockyer PJ: Integration of calcium and Ras signalling. Nat Rev Mol Cell Biol 2002, 3:339-348.
44. Kolbus A, Pilat S, Husak Z, Deiner EM, Stengl G, Beug H, Baccarini M: Raf-1 antagonizes erythroid differentiation by restraining caspase activation. J Exp Med 2002, 196:1347-1353.
45. Hall-Jackson CA, Eyers PA, Cohen P, Goedert M, Boyle FT, Hewitt N, Plant H, Hedge P: Paradoxical activation of Raf by a novel Raf inhibitor. Chem Biol 1999, 6:559-568.
46. Myklebust JH, Smeland EB, Josefsen D, Sioud M: Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow. Blood 2000, 95:510-518.
47. Lopez-Ilasaca M, Crespo P, Pellici PG, Gutkind JS, Wetzker R: Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 1997, 275:394-397.
48. Bondeva T, Pirola L, Bulgarelli-Leva G, Rubio I, Wetzker R, Wymann MP: Bifurcation of lipid and protein kinase signals of PI3Kgamma to the protein kinases PKB and MAPK. Science 1998, 282:293-296.
49. Wetzker R, Bohmer FD: Opinion: Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 2003, 4:651-657.
50. Stephens LR, Eguinoa A, Erdjument-Bromage H, Lui M, Cooke F, Coadwell J, Smrcka AS, Thelen M, Cadwallader K, Tempst P, Hawkins PT: The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 1997, 89:105-114.
51. Wymann MP, Bjorklof K, Calvez R, Finan P, Thomast M, Trifilieff A, Barbier M, Altruda F, Hirsch E, Laffargue M: Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy. Biochem Soc Trans 2003, 31:275-280.
52. Rubio I, Rodriguez-Viciana P, Downward J, Wetzker R: Interaction of Ras with phosphoinositide 3-kinase gamma. Biochem J 1997, 326 (Pt 3):891-895.
53. Pacold ME, Suire S, Perisic O, Lara-Gonzalez S, Davis CT, Walker EH, Hawkins PT, Stephens L, Eccleston JF, Williams RL: Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 2000, 103:931-943.
54. Guillard C, Chretien S, Jockers R, Fichelson S, Mayeux P, Duprez V: Coupling of heterotrimeric Gi proteins to the erythropoietin receptor. J Biol Chem 2001, 276:2007-2014.
55. Guillard C, Chretien S, Pelus AS, Porteu F, Muller O, Mayeux P, Duprez V: Activation of the mitogen-activated protein kinases Erk1/2 by erythropoietin receptor via a G(i )protein beta gamma-subunit-initiated pathway. J Biol Chem 2003, 278:11050-11056.
56. Li K, Menon MP, Karur VG, Hegde S, Wojchowski DM: Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells. Blood 2003, 102:3147-53.
57. Dhillon AS, Meikle S, Yazici Z, Eulitz M, Kolch W: Regulation of Raf-1 activation and signalling by dephosphorylation. Embo J 2002, 21:64-71.
58. Taylor SJ, Shalloway D: Cell cycle-dependent activation of Ras. Curr Biol 1996, 6:1621-1627.
59. Posern G, Weber CK, Rapp UR, Feller SM: Activity of Rap1 is regulated by bombesin, cell adhesion, and cell density in NIH3T3 fibroblasts. J Biol Chem 1998, 273:24297-24300.